Adult CF Centre, Department of Respirology, St. Michael's Hospital, Toronto, Ontario M5B 1W8, Canada.
Modélisation, Epidémiologie et Surveillance des Risques Sanitaires, Laboratoire Conservatoire National des Arts et Métiers, Paris, France.
J Cyst Fibros. 2019 May;18(3):396-398. doi: 10.1016/j.jcf.2018.10.014. Epub 2018 Nov 3.
Studies of large CF populations using registry data are important to identify people at high risk for death. Nkam et al. published a prognostic score developed on French CF registry data to predict death or lung transplantation (LT) over a 3-year period in the adult CF population. The goal of our study was to validate the proposed tool using the Canadian CF registry. Using data between 2011 and 2014, a total of 2043 adult CF patients were included. We found that the French prognostic score was a good predictor of death or LT in the Canadian CF population (OR for each unit increase: 3.12, 95% CI: 2.74-3.55; p value < 0.001). The proposed prognostic score accurately categorizes patients when applied to an external dataset. This score provides an important tool for early identification of patients at high risk for death or LT, in whom specific therapeutic intervention can be proposed.
利用注册数据对大型 CF 人群进行研究对于识别高死亡风险人群非常重要。Nkam 等人发表了一项基于法国 CF 注册数据的预后评分,用于预测成年 CF 人群中 3 年内的死亡或肺移植 (LT)。我们的研究目的是使用加拿大 CF 注册数据验证该工具。使用 2011 年至 2014 年的数据,共纳入 2043 例成年 CF 患者。我们发现,法国预后评分是加拿大 CF 人群中死亡或 LT 的良好预测指标(每增加一个单位的 OR:3.12,95%CI:2.74-3.55;p 值 < 0.001)。当应用于外部数据集时,该预后评分能够准确地对患者进行分类。该评分提供了一种重要的工具,用于早期识别死亡或 LT 风险较高的患者,以便提出特定的治疗干预措施。